What is Visikol's business focus and history?
Visikol is a contract research services company based in Hampton, New Jersey, founded in 2016 by Michael Johnson, Thomas Villani, and Nick Crider. It specializes in advanced tissue imaging and cell culture services to accelerate drug discovery and development. Visikol has raised funding from the National Science Foundation and the National Cancer Institute. The company was acquired by Sartorius in November 2025.
Visikol Corporate Details & Core Services
Visikol is a contract research services company specializing in advanced tissue imaging and cell culture services to accelerate drug discovery and development.
Visikol Contact Information & Official Links
Website
https://visikol.com
Social
Email id
info@visikol.com
Phone number
+1-800-615-8474
Head office address
Hampton, New Jersey, United States
Tags
contract research organization
tissue imaging
cell culture services
drug discovery
digital pathology
What are Visikol's Key Business Metrics & Stats?
No of employees
11
Founded year
2016
Type
private
SAICS CODE
8733
NAICS Code
541714
Industry
Biotechnology Research
Location
Hampton, New Jersey, United States
Parent Company
sartorius.com
Pricing Strategy
Custom pricing based on project scope
Visikol
Firmographic Snapshot
2026
2016
Founded Year
11
Global Employees
United States
Headquarters
Biotechnology Research
Industry
Private
Type
Verified by
DexterAgent.ai
How much funding has Visikol raised to date?
Name
Description
Funding Amount
USD 225 Thousand
Stage
SBIR Phase I
Latest Valuation
80 Million (USD)
Lead Investor
National Science Foundation
Investors
National Science Foundation
What are Visikol's Core Products?
Name
Description
Visikol HISTO
A suite of tissue clearing reagents and kits for 3D tissue imaging.
HUREL Micro Livers
Primary hepatocyte liver models for drug metabolism studies.
What are the latest developments at Visikol?
Date
Type
Description
November, 2025
Acquisition
Visikol acquired by Sartorius to enhance drug discovery and development services.
What industry awards and recognitions has Visikol received?
Date
Type
Description
May, 2021
Grant
Awarded $1.64M NIH NCI Phase II SBIR Award to develop imaging and digital pathology portfolio.
Visikol VS MatTek Life Sciences VS Sartorius : 2026 Comparison
Feature
Visikol
MatTek Life Sciences
Sartorius
Core Strengths
Visikol HISTO, HUREL Micro Livers
EpiDerm™, EpiOcular™, EpiAirway™
Bioreactors & Fermenters, Lab Balances, Pipettes, Single-Use Bags, Membrane Filters
Founded Year
2016
1985
1870
Stock Name/Ticker
SRT3 (Frankfurt Stock Exchange), DIM (Euronext Paris)
Type
private
private
public
Global Employees
11
80
14042
Revenue (Annual)
$3.8 Million(2025)
$20 Million(2024)
$3.5 Billion(2025)
Headquarters
Hampton, New Jersey, United States
Ashland, Massachusetts, United States
Göttingen, Lower Saxony, Germany
Latest Valuation
$80 Million
$80 Million
LATEST REVENUE (TRILLIONS USD)
EMPLOYEE COUNT (THOUSANDS)
INNOVATORS
VISIONARIES
DISRUPTORS
GIANTS
MatTek Life Sciences
20 | 80
Sartorius
3.5 | 14042
Competitive Landscape 2026
DexterAgent.ai
What are Visikol's official legal and registration details?
Name
Description
Legal Name
Visikol Inc.
Cin number
GST number
Registration number
Who is in Visikol's executive leadership team?
Name
Designation
CEO
Michael Johnson
Chief Science Officer
Thomas Villani
Chief Operating Officer
Nick Crider
Where are Visikol's primary office locations?
City
Country
Hampton
United States
Ashland
United States
Bratislava
Slovakia
What are the current business signals and market intelligence for Visikol?
Spending next 3 months
Integration with Sartorius, Expansion of service offerings
Pain points
Need for advanced tissue imaging, Requirement for accurate cell culture assays
Sales motion
Direct sales to pharmaceutical and biotech companies
Buyer Persona
Research scientists, Drug development professionals
Type of customer
Pharmaceutical companies, Biotech companies
Key customer domain
pharma.com, biotech.com
Annual ACV
$100,000 - $500,000
What is Visikol's annual revenue history?
Year
Revenue (USD)
2025
3.8 Million
What are Visikol's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
Saas
No
Offline Stores
No
Service
Yes
Ecommerce
No
Exporter
Yes
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
No
Wholesale
No
Importer
No